share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

SEC announcement ·  Mar 13 05:54
Summary by Futu AI
Bristol-Myers Squibb EVP, Karin Shanahan, completed a transaction involving the company's common stock on March 10, 2024. The action involved direct and indirect holdings, with Shanahan now owning a total of 3,226 shares directly and 818.59 shares indirectly through the BMS Savings and Investment Program. The common stock is listed with a par value of $0.10. This transaction reflects changes in the executive's stake in the company, which is a key interest for investors monitoring insider activity.
Bristol-Myers Squibb EVP, Karin Shanahan, completed a transaction involving the company's common stock on March 10, 2024. The action involved direct and indirect holdings, with Shanahan now owning a total of 3,226 shares directly and 818.59 shares indirectly through the BMS Savings and Investment Program. The common stock is listed with a par value of $0.10. This transaction reflects changes in the executive's stake in the company, which is a key interest for investors monitoring insider activity.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.